2009
DOI: 10.4161/cbt.8.24.10277
|View full text |Cite
|
Sign up to set email alerts
|

Superficial malignant tumors: Non-invasive treatment with ultrasonographically guided high-intensity focused ultrasound

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 18 publications
0
2
0
Order By: Relevance
“…MRgFUS trials and clinical protocols typically use tumor-to-skin proximity less than 1.0 cm as an exclusion criterion with the intention of avoiding skin burns [ 3 , 11 , 12 ], thereby reducing the number of patients eligible for this noninvasive therapy. If the patient is not excluded outright, the superficial portions of the tumor may not be targeted during treatment, reducing the likelihood of achieving an enduring clinical benefit.…”
Section: Introductionmentioning
confidence: 99%
“…MRgFUS trials and clinical protocols typically use tumor-to-skin proximity less than 1.0 cm as an exclusion criterion with the intention of avoiding skin burns [ 3 , 11 , 12 ], thereby reducing the number of patients eligible for this noninvasive therapy. If the patient is not excluded outright, the superficial portions of the tumor may not be targeted during treatment, reducing the likelihood of achieving an enduring clinical benefit.…”
Section: Introductionmentioning
confidence: 99%
“…Superficial malignant tumors (SMTs), such as breast cancers and melanoma, are increasingly aggressive diseases with strong elusiveness and high metastatic potential. , According to the National Cancer Institute, approximate 90% of surviving rates has been afforded for both breast cancers and melanoma . Thus, effective strategies of precise diagnosis and treatment against superficial malignant tumor lesions are of great significance.…”
mentioning
confidence: 99%